357 related articles for article (PubMed ID: 23337808)
1. Wiskott-Aldrich syndrome protein-mediated actin dynamics control type-I interferon production in plasmacytoid dendritic cells.
Prete F; Catucci M; Labrada M; Gobessi S; Castiello MC; Bonomi E; Aiuti A; Vermi W; Cancrini C; Metin A; Hambleton S; Bredius R; Notarangelo LD; van der Burg M; Kalinke U; Villa A; Benvenuti F
J Exp Med; 2013 Feb; 210(2):355-74. PubMed ID: 23337808
[TBL] [Abstract][Full Text] [Related]
2. Neutrophils drive type I interferon production and autoantibodies in patients with Wiskott-Aldrich syndrome.
Cervantes-Luevano KE; Caronni N; Castiello MC; Fontana E; Piperno GM; Naseem A; Uva P; Bosticardo M; Marcovecchio GE; Notarangelo LD; Cicalese MP; Aiuti A; Villa A; Benvenuti F
J Allergy Clin Immunol; 2018 Nov; 142(5):1605-1617.e4. PubMed ID: 29447842
[TBL] [Abstract][Full Text] [Related]
3. Reduced type I interferon production by dendritic cells and weakened antiviral immunity in patients with Wiskott-Aldrich syndrome protein deficiency.
Lang PA; Shaabani N; Borkens S; Honke N; Scheu S; Booth S; Brenner D; Meryk A; Barthuber C; Recher M; Mak TW; Ohashi PS; Häussinger D; Griffiths GM; Thrasher AJ; Bouma G; Lang KS
J Allergy Clin Immunol; 2013 Mar; 131(3):815-24. PubMed ID: 23141740
[TBL] [Abstract][Full Text] [Related]
4. Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation.
Gotoh K; Tanaka Y; Nishikimi A; Nakamura R; Yamada H; Maeda N; Ishikawa T; Hoshino K; Uruno T; Cao Q; Higashi S; Kawaguchi Y; Enjoji M; Takayanagi R; Kaisho T; Yoshikai Y; Fukui Y
J Exp Med; 2010 Apr; 207(4):721-30. PubMed ID: 20231379
[TBL] [Abstract][Full Text] [Related]
5. The chemotactic defect in wiskott-Aldrich syndrome macrophages is due to the reduced persistence of directional protrusions.
Ishihara D; Dovas A; Park H; Isaac BM; Cox D
PLoS One; 2012; 7(1):e30033. PubMed ID: 22279563
[TBL] [Abstract][Full Text] [Related]
6. The Wiskott-Aldrich syndrome: The actin cytoskeleton and immune cell function.
Blundell MP; Worth A; Bouma G; Thrasher AJ
Dis Markers; 2010; 29(3-4):157-75. PubMed ID: 21178275
[TBL] [Abstract][Full Text] [Related]
7. The role of WASp in T cells and B cells.
Sun X; Wei Y; Lee PP; Ren B; Liu C
Cell Immunol; 2019 Jul; 341():103919. PubMed ID: 31047647
[TBL] [Abstract][Full Text] [Related]
8. Effects of Wiskott-Aldrich Syndrome Protein Deficiency on IL-10-Producing Regulatory B Cells in Humans and Mice.
Du HQ; Zhang X; An YF; Ding Y; Zhao XD
Scand J Immunol; 2015 Jun; 81(6):483-93. PubMed ID: 25728049
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic lineage cell-specific protein 1 functions in concert with the Wiskott-Aldrich syndrome protein to promote podosome array organization and chemotaxis in dendritic cells.
Dehring DA; Clarke F; Ricart BG; Huang Y; Gomez TS; Williamson EK; Hammer DA; Billadeau DD; Argon Y; Burkhardt JK
J Immunol; 2011 Apr; 186(8):4805-18. PubMed ID: 21398607
[TBL] [Abstract][Full Text] [Related]
10. Nuclear role of WASp in the pathogenesis of dysregulated TH1 immunity in human Wiskott-Aldrich syndrome.
Taylor MD; Sadhukhan S; Kottangada P; Ramgopal A; Sarkar K; D'Silva S; Selvakumar A; Candotti F; Vyas YM
Sci Transl Med; 2010 Jun; 2(37):37ra44. PubMed ID: 20574068
[TBL] [Abstract][Full Text] [Related]
11. Disease-associated missense mutations in the EVH1 domain disrupt intrinsic WASp function causing dysregulated actin dynamics and impaired dendritic cell migration.
Worth AJ; Metelo J; Bouma G; Moulding D; Fritzsche M; Vernay B; Charras G; Cory GO; Thrasher AJ; Burns SO
Blood; 2013 Jan; 121(1):72-84. PubMed ID: 23160469
[TBL] [Abstract][Full Text] [Related]
12. Wiskott-Aldrich syndrome protein regulates autophagy and inflammasome activity in innate immune cells.
Lee PP; Lobato-Márquez D; Pramanik N; Sirianni A; Daza-Cajigal V; Rivers E; Cavazza A; Bouma G; Moulding D; Hultenby K; Westerberg LS; Hollinshead M; Lau YL; Burns SO; Mostowy S; Bajaj-Elliott M; Thrasher AJ
Nat Commun; 2017 Nov; 8(1):1576. PubMed ID: 29146903
[TBL] [Abstract][Full Text] [Related]
13. Wiskott-Aldrich syndrome protein deficiency in innate immune cells leads to mucosal immune dysregulation and colitis in mice.
Nguyen DD; Wurbel MA; Goettel JA; Eston MA; Ahmed OS; Marin R; Boden EK; Villablanca EJ; Paidassi H; Ahuja V; Reinecker HC; Fiebiger E; Lacy-Hulbert A; Horwitz BH; Mora JR; Snapper SB
Gastroenterology; 2012 Sep; 143(3):719-729.e2. PubMed ID: 22710191
[TBL] [Abstract][Full Text] [Related]
14. Impaired dendritic-cell homing in vivo in the absence of Wiskott-Aldrich syndrome protein.
de Noronha S; Hardy S; Sinclair J; Blundell MP; Strid J; Schulz O; Zwirner J; Jones GE; Katz DR; Kinnon C; Thrasher AJ
Blood; 2005 Feb; 105(4):1590-7. PubMed ID: 15494425
[TBL] [Abstract][Full Text] [Related]
15. WASP (Wiskott-Aldrich syndrome protein) gene mutations and phenotype.
Imai K; Nonoyama S; Ochs HD
Curr Opin Allergy Clin Immunol; 2003 Dec; 3(6):427-36. PubMed ID: 14612666
[TBL] [Abstract][Full Text] [Related]
16. FLI1 Induces Megakaryopoiesis Gene Expression Through WAS/WIP-Dependent and Independent Mechanisms; Implications for Wiskott-Aldrich Syndrome.
Wang C; Sample KM; Gajendran B; Kapranov P; Liu W; Hu A; Zacksenhaus E; Li Y; Hao X; Ben-David Y
Front Immunol; 2021; 12():607836. PubMed ID: 33717090
[TBL] [Abstract][Full Text] [Related]
17. Antigen receptor-induced activation and cytoskeletal rearrangement are impaired in Wiskott-Aldrich syndrome protein-deficient lymphocytes.
Zhang J; Shehabeldin A; da Cruz LA; Butler J; Somani AK; McGavin M; Kozieradzki I; dos Santos AO; Nagy A; Grinstein S; Penninger JM; Siminovitch KA
J Exp Med; 1999 Nov; 190(9):1329-42. PubMed ID: 10544204
[TBL] [Abstract][Full Text] [Related]
18. Wiskott-Aldrich Syndrome at the nexus of autoimmune and primary immunodeficiency diseases.
Cleland SY; Siegel RM
FEBS Lett; 2011 Dec; 585(23):3710-4. PubMed ID: 22036785
[TBL] [Abstract][Full Text] [Related]
19. Human Plasmacytoid and Monocyte-Derived Dendritic Cells Display Distinct Metabolic Profile Upon RIG-I Activation.
Fekete T; Sütö MI; Bencze D; Mázló A; Szabo A; Biro T; Bacsi A; Pazmandi K
Front Immunol; 2018; 9():3070. PubMed ID: 30622542
[TBL] [Abstract][Full Text] [Related]
20. Use of zinc-finger nucleases to knock out the WAS gene in K562 cells: a human cellular model for Wiskott-Aldrich syndrome.
Toscano MG; Anderson P; Muñoz P; Lucena G; Cobo M; Benabdellah K; Gregory PD; Holmes MC; Martin F
Dis Model Mech; 2013 Mar; 6(2):544-54. PubMed ID: 23324327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
